JP2004529079A5 - - Google Patents

Download PDF

Info

Publication number
JP2004529079A5
JP2004529079A5 JP2002549276A JP2002549276A JP2004529079A5 JP 2004529079 A5 JP2004529079 A5 JP 2004529079A5 JP 2002549276 A JP2002549276 A JP 2002549276A JP 2002549276 A JP2002549276 A JP 2002549276A JP 2004529079 A5 JP2004529079 A5 JP 2004529079A5
Authority
JP
Japan
Prior art keywords
cox
extract
eyes
composition
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002549276A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004529079A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/048650 external-priority patent/WO2002047706A2/en
Publication of JP2004529079A publication Critical patent/JP2004529079A/ja
Publication of JP2004529079A5 publication Critical patent/JP2004529079A5/ja
Withdrawn legal-status Critical Current

Links

JP2002549276A 2000-12-15 2001-12-13 植物抽出物による選択的ｃｏｘ−２阻害 Withdrawn JP2004529079A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30420700P 2000-12-15 2000-12-15
PCT/US2001/048650 WO2002047706A2 (en) 2000-12-15 2001-12-13 Selective cox-2 inhibition from plant extracts

Publications (2)

Publication Number Publication Date
JP2004529079A JP2004529079A (ja) 2004-09-24
JP2004529079A5 true JP2004529079A5 (enExample) 2006-01-12

Family

ID=23175530

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002549276A Withdrawn JP2004529079A (ja) 2000-12-15 2001-12-13 植物抽出物による選択的ｃｏｘ−２阻害

Country Status (5)

Country Link
US (2) US20020136784A1 (enExample)
EP (1) EP1401460A2 (enExample)
JP (1) JP2004529079A (enExample)
AU (1) AU2002229074A1 (enExample)
WO (1) WO2002047706A2 (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7108868B2 (en) 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US20030165588A1 (en) 2002-03-01 2003-09-04 Unigen Pharmaceuticals, Inc. Identification of free-B-ring flavonoids as potent COX-2 inhibitors
US7972632B2 (en) * 2003-02-28 2011-07-05 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
US8034387B2 (en) * 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US8945518B2 (en) * 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
DE60328676D1 (de) * 2002-04-30 2009-09-17 Unigen Pharmaceuticals Inc Formulierung eines gemisches aus flavonoiden und flavanen mit freiem b ring als therapeutisches mittel
JP2004196696A (ja) * 2002-12-18 2004-07-15 Kyowa Hakko Kogyo Co Ltd 関節炎の予防剤または治療剤
FR2851919A1 (fr) * 2003-03-03 2004-09-10 Lmd Lignanes utilisables comme inhibiteurs de cathepsines et leurs applications
EP1631304A4 (en) * 2003-04-04 2007-03-21 Unigen Pharmaceuticals Inc FORMULATION OF DUAL CYCLOXYGENASE (COX) AND LIPOXYGENASE (LOX) INHIBITORS FOR THE SKIN CARE OF MAMMALS
FR2854799A1 (fr) * 2003-05-16 2004-11-19 Cognis France Sa Utilisation d'extraits des graines de plantes appartenant au genre adenanthera pour la fabrication de preparations cosmetiques et/ou dermatologiques
CN1845750B (zh) * 2003-09-02 2014-05-07 尤尼根公司 用于预防及治疗认知衰退和年龄相关的记忆障碍的无取代b环类黄酮和黄烷混合物的组合物
DE10394347T5 (de) * 2003-12-22 2007-05-16 Council Scient Ind Res Eine synergistische Zusammensetzung zur Behandlung von Hyperlipidämie
JP4836418B2 (ja) * 2004-07-29 2011-12-14 丸善製薬株式会社 抗酸化剤、抗炎症剤、美白剤及び皮膚化粧料
KR100545304B1 (ko) * 2004-09-01 2006-05-08 주식회사 유니젠 아선약을 포함하는 운카리아 속 식물, 또는 이의 황금및/또는 녹차의 배합물을 포함하는 사이클로옥시게나제및/또는 5-리폭시게나제 억제용 조성물
US20060198872A1 (en) * 2005-03-07 2006-09-07 Chioma Ikonte Plant based dietary supplement for improving the duration and quality of sleep
EP2529626B1 (en) * 2006-05-01 2017-11-22 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing colon cancer
US7282224B1 (en) 2006-06-09 2007-10-16 Guthy-Renker Corporation Pain relief composition
KR100761248B1 (ko) * 2006-10-12 2007-10-04 주식회사 유니젠 대나무 및 황금 추출물을 유효성분으로 함유하는 아토피성피부염 치료를 위한 조성물
US20080107747A1 (en) * 2006-10-23 2008-05-08 Roederer Joy E Pain relief composition
KR100791108B1 (ko) 2006-11-06 2008-01-03 제주대학교 산학협력단 방사선 방호효과를 갖는 담팔수 분획농축물과 그 제조방법
FR2922765B1 (fr) * 2007-10-25 2014-11-28 Inst Rech Developpement Ird Utilisation d'une huile essentielle pour la preparation d'une composition cosmetique ou pharmaceutique
KR100982022B1 (ko) * 2008-03-11 2010-09-13 한동열 신경세포 손상의 예방 또는 치료용 조성물
FR2943247B1 (fr) 2009-03-20 2012-11-30 Natura Cosmeticos Sa Procede pour obtenir des substances insolubles a partir de precipites d'extrait de genipap, substances ainsi obtenues et leurs utilisations
KR101057483B1 (ko) 2009-04-09 2011-08-17 한동열 9-히드록시-알파-토코페론을 포함하는 신경세포 손상의 예방 또는 치료용 조성물
EP2470161B1 (en) 2009-08-26 2015-10-07 Mary Kay, Inc. Topical skin care formulations comprising plant extracts
KR101167677B1 (ko) * 2009-09-21 2012-07-20 한국생명공학연구원 엘리오카퍼스 페티오라투스 추출물을 함유하는 염증성 질환 예방 및 치료용 조성물
US9220675B2 (en) 2010-09-09 2015-12-29 Mary Kay Inc. Topical skin care formulations comprising plant extracts
KR101425560B1 (ko) * 2010-12-07 2014-08-04 한국생명공학연구원 엘리오카퍼스 페티오라투스 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화용 조성물
WO2012077976A2 (ko) * 2010-12-07 2012-06-14 한국생명공학연구원 엘리오카퍼스 페티오라투스 추출물 또는 이의 분획물을 유효성분으로 함유하는 노화방지용 조성물
DE102011109522A1 (de) * 2011-08-05 2013-02-07 Merck Patent Gmbh Extrakte aus Tradescantia virginiana
CA2854979C (en) * 2011-12-13 2020-05-26 Avon Products, Inc. Maesa japonica extracts and methods of use
US8632827B2 (en) 2011-12-13 2014-01-21 Avon Products, Inc Modulation of thymosin beta-4 in skin
TWI637751B (zh) * 2012-12-11 2018-10-11 美商愛芳製品公司 山桂花（ｍａｅｓａ ｊａｐｏｎｉｃａ）萃取物及使用方法
JP2014177454A (ja) * 2013-02-18 2014-09-25 Kagoshima Univ ねじめびわ茶抽出物を含有する飲食品及び医薬品
JP2016132633A (ja) * 2015-01-19 2016-07-25 農業生産法人 有限会社十津川農場 ねじめびわ茶のアルツハイマー症予防又は治療作用
JP6485836B2 (ja) * 2015-12-28 2019-03-20 株式会社佐藤園 イグサ由来シクロオキシゲナーゼ−２阻害剤
US10821148B2 (en) * 2016-01-26 2020-11-03 Industrial Technology Research Institute Pharmaceutical composition for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis and method for treating or alleviating an autoimmune disease and/or complication thereof and/or nephritis
ES2883168T3 (es) 2016-05-03 2021-12-07 Tauderma Sa Extractos de saxifraga para uso cosmético o terapéutico en la piel
KR101806031B1 (ko) 2016-07-11 2017-12-08 한양대학교 에리카산학협력단 마카커진 ｃ 또는 이의 유도체를 함유하는 항염증 활성 조성물 및 이의 제조방법
KR102015448B1 (ko) * 2017-12-08 2019-08-28 성균관대학교산학협력단 검팽나무 추출물을 유효성분으로 포함하는 항염증 조성물
KR102284073B1 (ko) * 2019-10-14 2021-08-02 한국해양과학기술원 항염증 활성을 갖는 남극 지의류 움빌리카리아 안타티카 추출물 및 이를 함유하는 조성물

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4324785A (en) * 1980-05-20 1982-04-13 Emma S. Stevens Foot powder
US4313958A (en) * 1980-10-24 1982-02-02 The Procter & Gamble Company Method of producing analgesia
JPS5824523A (ja) * 1981-08-07 1983-02-14 Terumo Corp 抗悪性新生物剤
JPS5936619A (ja) * 1982-08-23 1984-02-28 Tsumura Juntendo Inc 制癌補助剤
US4767626A (en) * 1985-03-11 1988-08-30 Theodore Cheng Remedy for anemia and arthritis
US5380738A (en) * 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
US5344991A (en) * 1993-10-29 1994-09-06 G.D. Searle & Co. 1,2 diarylcyclopentenyl compounds for the treatment of inflammation
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
RO118291B1 (ro) * 1993-11-30 2003-04-30 Searle & Co Derivati de pirazol 1,3,4,5 - tetrasubstituiti si compozitie farmaceutica care ii contine
US5393790A (en) * 1994-02-10 1995-02-28 G.D. Searle & Co. Substituted spiro compounds for the treatment of inflammation
US5824312A (en) * 1994-03-10 1998-10-20 Imarx Pharmaceutical Corp. Sunscreen agents from natural sources
US5633272A (en) * 1995-02-13 1997-05-27 Talley; John J. Substituted isoxazoles for the treatment of inflammation
JP2732504B2 (ja) * 1995-03-08 1998-03-30 農林水産省中国農業試験場長 アラキドン酸代謝活性阻害剤とその製造法
US5762963A (en) * 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
JPH0967360A (ja) * 1995-08-28 1997-03-11 Terumo Corp 癌遺伝子機能抑制剤
WO1997038986A1 (en) * 1996-04-12 1997-10-23 G.D. Searle & Co. Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
JP4346685B2 (ja) * 1996-10-21 2009-10-21 ユーロビタ アクティーゼルスカブ パルテニウム・インテグリフォリウム又はその部分若しくはそのエキス又はその成分を含有する医薬組成物、かかる植物材料の医薬製造のための使用、及びパルテニウム・インテグリフォリウムのエキスの製造方法
US5811425A (en) * 1997-03-04 1998-09-22 Abbott Laboratories Heterocyclic compounds as COX-2 inhibitors
JP4231559B2 (ja) * 1997-04-23 2009-03-04 オリザ油化株式会社 リポキシゲナーゼ阻害剤
AU7799398A (en) * 1997-05-27 1998-12-30 Algos Pharmaceutical Corporation Analgesic drug composition containing a capsaicinoid and potentiator therefor
AUPP797598A0 (en) * 1998-12-30 1999-01-28 Butters, Desley Therapeutic agent
US6194469B1 (en) * 1998-12-11 2001-02-27 Board Of Trustees Operating Michigan State Univeristy Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids
JP4397991B2 (ja) * 1999-02-16 2010-01-13 株式会社ロッテ 抗発癌プロモーター剤
US20010006686A1 (en) * 1999-03-19 2001-07-05 David G. Corley Inflammatory mediation obtained from atractylodes lancea
AU779928B2 (en) * 1999-05-27 2005-02-17 Michael Z. Martin Pharmaceutical preparations of bioactive substances extracted from natural sources
US6197823B1 (en) * 1999-09-29 2001-03-06 Medical Merchandising, Inc. Pain reliever and method of use
US6348501B1 (en) * 1999-09-29 2002-02-19 Medical Merchandising, Inc. Lotion compositions utilizing capsaicin
US6310091B1 (en) * 2000-09-14 2001-10-30 The United States Of America As Represented By The Secretary Of Agriculture Fungicidal saponin, CAY-1, and isolation thereof from Capsium species fruit

Similar Documents

Publication Publication Date Title
JP2004532811A5 (enExample)
Zhou et al. GSK-3β inhibitors suppressed neuroinflammation in rat cortex by activating autophagy in ischemic brain injury
Ma et al. Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2
Aroonrerk et al. Anti-inflammatory activity of Quercus infectoria, Glycyrrhiza uralensis, Kaempferia galanga and Coptis chinensis, the main components of Thai herbal remedies for aphthous ulcer
Mei et al. Antipyretic and anti-asthmatic activities of traditional Chinese herb-pairs, Ephedra and Gypsum
Yu et al. Efficacy and safety of total glucosides of paeony combined with acitretin in the treatment of moderate-to-severe plaque psoriasis: a double-blind, randomised, placebo-controlled trial
Upadhayay et al. Frequently used allopathic and traditional medicine for COVID-19 treatment and feasibility of their integration
CN103285155B (zh) 一种治疗湿疹皮炎的中药组合物
Xu et al. Enhancement of wound healing by the traditional Chinese medicine herbal mixture Sophora flavescens in a rat model of perianal ulceration
JP2016505561A5 (enExample)
FI3989962T3 (fi) Asetyylileusiinia ja miglustaattia sisältävä yhdistelmähoito lysosomaalisen kertymäsairauden hoidossa
JP2011503008A5 (enExample)
CN110946903B (zh) 用于防治系统性硬化病的中药组合物及其应用
US20170281704A1 (en) Anti dengue activity of cissampelos pareira extracts
CN108042589A (zh) 片仔癀及其制剂在制备治疗带状疱疹的药物中的新用途
CN102512489B (zh) 一种治疗皮肤病的外用软膏
Gulati et al. Assessment of protective role of polyherbal preparation, Livina, against anti-tubercular drug induced liver dysfunction
CN102988734A (zh) 一种治疗心源性哮喘的中药
CN104288684A (zh) 治疗精神分裂症的药物组合物
CN104922463B (zh) 一种治疗小儿风热犯表型水痘的中药膏及其制备方法
CN104623379A (zh) 一种治疗小儿手足口病的药物组合物
Jiao et al. How to deal with omicron-traditional chinese medicine-enhance human immunity!
KR102451254B1 (ko) 코로나바이러스 감염증의 예방, 경감 또는 치료용 약학 조성물
CN100482250C (zh) 一种治疗带状疱疹或细菌感染所致皮肤病的外用中药组合物
Bharathi et al. Assessment of anti-psoriatic activity of ethanolic extract of Justicia tranquebariensis Linn. on amelioration of IMQ-induced hyperkeratosis in Balb/C mice